Genome Editing Market Forecast to 2028

Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, Antisense, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

Report Code : TIPHE100000853 | Region : Global | Industry : Biotechnology | Published Date : 14/Jan/2022

The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow at a CAGR of 18.4% from 2021 to 2028.

Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9—a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease—is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements.

A team from MIT and Harvard's Broad Institute has developed a novel CRISPR genome-editing technique that has the potential to fix up to 89% of disease-causing genetic abnormalities. CRISPR-Cas9 and reverse transcriptase, two of the most significant proteins in molecular biology, have been merged into a single machine by researchers. Prime editing is a method that can alter human cells directly in a precise, efficient, and highly versatile manner. They have also developed a CRISPR RNA-cutting enzyme into an antiviral agent that can be programmed to detect and eliminate RNA-based viruses in human cells. The Cas13 enzyme has previously been used to cut and alter human RNA and as a diagnostic approach for detecting the presence of viruses, bacteria, and other targets. This is one of the first studies to use Cas13, or any CRISPR system, as an antiviral in human cells in culture.

Recognizing the potential of genome editing techniques for studying and manipulating the genome., the Department of Biotechnology (DBT), Govt. of India has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development ( R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness Centers for Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC) are among the primary and secondary sources referred to while preparing the report on the genome editing market.

Rise in Prevalence of Cancer to Drive Global Genome Editing Market

According to our new research study on “Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User,” the market is expected to grow from US$ 5.19 billion in 2021 to US$ 16.98 billion by 2028; it is estimated to grow at a CAGR of 18.4% during 2021-2028. Factors contributing to the growth of the market that are the rising prevalence of cancer, growing rate of genetic disorders, and rapidly growing research and development initiatives around gene editing tools and techniques.

According to the World Health Organization (WHO), cancer is the biggest cause of death worldwide, with approx. 10 million deaths in 2020. Overall, the global burden of cancer incidence and death is rapidly increasing, reflecting both population aging and growth, as well as changes in the prevalence and distribution of the key risk factors, many of which are related to socio-economic development. As per the recent estimates from CANCER TODAY, the incidence of cancer has been increasing at an alarming rate, making hepatocellular carcinoma (HCC) the fifth most common cancer in men and the seventh most common cancer in women. HCC is likely to contribute to ~5.6% of all human cancers, thereby increasing the burden in 2020. The HCC is known to be the second leading cause of cancer-related deaths worldwide. Almost 85% of HCCs occur in developing countries. Due to the advancement in human genomics from last two decades, researchers have discovered that cancer is caused by somatic aberrations in the host genome. This discovery has incited enthusiasm among cancer researchers. Many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease. Many cancer biology investigations are now using CRISPR as a standard approach. The CRISPR/Cas9 system has been shown to be effective in treating metastatic tumors, which is a big step toward discovering a cancer cure.

Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Horizon Discovery Group plc., Integrated DNA Technologies, GenScript, New England Biolabs, Eurofins Scientific, CRISPR Therapeutics, and Editas Medicine are among the leading companies operating in the genome editing market.

Based on technology, the genome editing market is segmented into CRISPR, TALEN, antisense, and other. Based on application, the market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery, and others. Based on end user, the genome editing market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations (CRO's). By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Genome Editing Market– By Technology

1.3.2 Genome Editing Market– By Application

1.3.3 Genome Editing Market– By End User

1.3.4 Genome Editing Market– By Geography

2. Genome Editing Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Genome Editing Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Expert Opinion

5. Genome Editing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders

5.1.2 Continuous Technological Advancements in Gene-Editing Tools

5.2 Market Restraints

5.2.1 High Cost of Genomic Equipment

5.3 Market Opportunities

5.3.1 Developing Biotechnology Industry in Emerging Regions

5.4 Future Trends

5.4.1 Technological Innovations

5.5 Impact Analysis

6. Genome Editing Market– Global Analysis

6.1 Global Genome Editing Market Revenue Forecast and Analysis

6.2 Global Genome Editing Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Genome Editing Market Revenue and Forecasts To 2028– by Technology

7.1 Overview

7.2 Global Genome Editing Market, By Technology, 2021 & 2028 (%)

7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

7.3.1 Overview

7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.4 TALEN

7.4.1 Overview

7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.5 Antisense

7.5.1 Overview

7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8. Genome Editing Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Global Genome Editing Market Share, By Application - 2021 & 2028 (%)

8.3 Cell Line Engineering

8.3.1 Overview

8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genetic Engineering

8.4.1 Overview

8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Diagnostic Applications

8.5.1 Overview

8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.6 Drug Discovery

8.6.1 Overview

8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9. Genome Editing Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 Global Genome Editing Market Share by End User - 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Clinical Research Organizations (CRO’s)

9.4.1 Overview

9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10. Genome Editing Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Genome Editing Market

10.1.1 Overview

10.1.2 North America: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.4 North America: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.5 North America: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.1.6 North America: Genome Editing Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.6.1.4 US: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.6.1.5 US: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.1.6.2 Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.6.2.5 Canada: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.6.3.5 Mexico: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.2 Europe: Genome Editing Market

10.2.1 Overview

10.2.2 Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.4 Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.4.1 Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)

10.2.5.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.1.1 Overview

10.2.5.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.2.1 Overview

10.2.5.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.3.1 Overview

10.2.5.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.4.1 Overview

10.2.5.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.5.1 Overview

10.2.5.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.5.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.6.1 Overview

10.2.5.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.5.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.5.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

10.2.5.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3 Asia Pacific: Genome Editing Market Revenue and Forecast to 2028

10.3.1 Overview

10.3.2 Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.3 Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.4 Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.5 Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6 Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.3 China: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.4 China: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.1.5 China: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6.2 Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.3 Japan: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.4 Japan: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.2.5 Japan: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6.3 India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.3 India: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.4 India: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.3.5 India: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6.4 South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.3 South Korea: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.4 South Korea: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.4.5 South Korea: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6.5 Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.3 Australia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.4 Australia: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.5.5 Australia: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)

10.4 Middle East & Africa Genome Editing Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.3 Middle East & Africa: Genome Editing Market Revenue and Forecast to 2028, Technology (US$ Million)

10.4.4 Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

10.4.4.1 Middle East & Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.5 Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)

10.4.5.1 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.1.1 Overview

10.4.5.1.2 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.1.3 UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.4.5.1.4 UAE: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.4.5.1.5 UAE: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.5.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.2.1 Overview

10.4.5.2.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.2.3 Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.4.5.2.4 Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.4.5.2.5 Saudi Arabia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.5.3 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.3.1 Overview

10.4.5.3.2 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.3.3 South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.4.5.3.4 South Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.4.5.3.5 South Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.5.4 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.4.1 Overview

10.4.5.4.2 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.4.5.4.3 Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.4.5.4.4 Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.4.5.4.5 Rest of Middle East and Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5 South and Central America: Genome Editing Market Revenue and Forecast To 2028

10.5.1 Overview

10.5.2 South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.5.4 South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

10.5.5 South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)

10.5.6.1 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.4 Argentina: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.5.6.1.5 Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.4 Brazil: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.5.6.2.5 Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.3 Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.4 Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)

10.5.6.3.5 Rest of South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Genome Editing Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Genome Editing Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Lonza

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Horizon Discovery Group plc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Integrated DNA Technologies

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 GenScript

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Eurofins Scientific

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 CRISPR Therapeutics

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Editas Medicine

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 Glossary of Terms

LIST OF TABLES.

Table 1. North America Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Genome Editing Market, End User– Revenue and Forecast to 2028 (US$ Million)

Table 4. US Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 6. US Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 18. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 20. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 21. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 23. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 24. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 28. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 34. Asia Pacific: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 35. Asia Pacific: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 36. Asia Pacific: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. China: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 38. China: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 39. China: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 40. Japan: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 41. Japan: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 42. Japan: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 43. India: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 44. India: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 45. India: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 46. South Korea: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 47. South Korea: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 48. South Korea: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 49. Australia: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 50. Australia: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 51. Australia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Asia Pacific: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Asia Pacific: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Asia Pacific: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 55. Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 56. Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 57. Middle East & Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 58. UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 59. UAE: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 60. UAE: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 61. Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 62. Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 63. Saudi Arabia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 64. South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 65. South Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 66. South Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 67. Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 68. Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 69. Rest of Middle East and Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 70. South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 71. South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 72. South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 73. Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 74. Argentina: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 75. Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 76. Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 77. Brazil: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 78. Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 79. Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)

Table 80. Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)

Table 81. Rest of South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 82. Organic Developments Done by Companies

Table 83. Inorganic Developments Done by Companies

Table 84. Glossary of Terms, Genome Editing Market

LIST OF FIGURES.

Figure 1. Genome Editing Market Segmentation

Figure 2. Cell Therapy Bioprocessing Segmentation, By Region

Figure 3. Global Genome Editing Market Overview

Figure 4. CRISPR Held Largest Share of Technology Segment in Genome Editing Market

Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6. Genome Editing Market, by Geography (US$ Million)

Figure 7. Global Genome Editing Market– Leading Country Markets (US$ Million)

Figure 8. Global Genome Editing Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Expert Opinion

Figure 15. Genome Editing Market Impact Analysis of Drivers and Restraints

Figure 16. Global Genome Editing Market– Revenue Forecast and Analysis – 2020-2028

Figure 17. Global Genome Editing Market– By Geography Forecast and Analysis – 2020-2028

Figure 18. Market Positioning of Key Players in Global Genome Editing Market

Figure 19. Global Genome Editing Market, by Technology, 2021 & 2028 (%)

Figure 20. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Global Genome Editing Market Share, by Application - 2021 & 2028 (%)

Figure 25. Cell Line Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Genetic Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27. Diagnostic Applications: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Drug Discovery: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. Others: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Global Genome Editing Market Share by End User - 2021 & 2028 (%)

Figure 31. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. North America: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 35. North America Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 37. US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 41. Europe: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 42. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 43. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Asia Pacific: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 50. Asia Pacific: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 51. Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 52. China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 53. Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 54. India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 55. South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 56. Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 57. Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 58. Middle East & Africa Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 59. Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 60. Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 61. UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 63. South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 64. Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 65. South and Central America: Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 66. South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 67. South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 68. Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 69. Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 70. Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 71. Impact of COVID-19 Pandemic in North American Country Markets

Figure 72. Impact of COVID-19 Pandemic in European Country Markets

Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 74. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 76. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Genome Editing Market

1. THERMO FISHER SCIENTIFIC INC.

2. MERCK KGaA

3. Lonza

4. Horizon Discovery Group plc.

5. Integrated DNA Technologies

6. GenScript

7. New England Biolabs

8. Eurofins Scientific

9. CRISPR Therapeutics

10. Editas Medicine

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genome editing market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global genome editing market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TOP